Video-supervised Motor and Awareness Training in Writer's Cramp
Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Oct 26, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called writer's cramp, which makes it hard to write due to involuntary muscle contractions. The trial will explore how effective a 12-month training program is in helping patients manage this condition. Participants will take part in one of two training programs: one focusing on sensorimotor skills and the other on awareness training. Both programs will include video supervision to help patients practice from anywhere. Researchers will measure the success of the treatments using a special questionnaire and various assessments of writing ability and brain activity.
To be eligible for this trial, participants must be right-handed and diagnosed with writer's cramp. They should also be able to join video calls. People with other neurological or psychiatric conditions, left-handed individuals, and those who have recently received certain treatments will not be included. Overall, this study is considered low-risk, with minimal side effects expected from the training, and the MRI scans used to study brain activity are similar to standard MRI procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Right handed idiopathic WC according to standardized criteria (simple and complex WC, any dystonic posture (including flexion, extension, pronation, supination))
- • able to participate in video-calls
- Exclusion Criteria:
- • Additional neurological or psychiatric diseases
- • left-handed patients
- • last botulinum toxin treatment \<3 months, remaining weakness from the last injection
- • concomitant use of anticholinergics or sedating medication
- Exclusion criteria for MRI:
- • Cardiac pacemaker, electronic or metal implants
- • pregnancy or suspected pregnancy
- • severe ametropia, anxiety in small rooms
About University Hospital Schleswig Holstein
University Hospital Schleswig-Holstein (UKSH) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution, UKSH integrates cutting-edge medical research with comprehensive patient care, fostering an environment that promotes the development of novel therapeutic strategies. With a multidisciplinary approach and a strong emphasis on collaboration, UKSH is dedicated to enhancing clinical outcomes and contributing to the global medical community through rigorous scientific inquiry and the translation of research findings into practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kiel, Schleswig Holstein, Germany
Patients applied
Trial Officials
Kirsten E Zeuner, Prof. MD
Principal Investigator
Kiel University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials